BACKGROUND
Pyruvate kinase deficiency is caused by mutations in
PKLR and leads to congenital hemolytic anemia. Mitapivat is an oral, small-molecule allosteric activator of
pyruvate kinase in red cells.
In this uncontrolled, phase 2 study, we evaluated the